A Cost-Utility Analysis of Ablative Therapy for Barrett's Esophagus
Authors:
- 1 June 2009
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 136 (7) , 2101-2114.e6
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- Eradication of Barrett Esophagus with Early Neoplasia by Radiofrequency Ablation, with or without Endoscopic ResectionJournal of Gastrointestinal Surgery, 2008
- Endoscopic endoluminal radiofrequency ablation of Barrett’s esophagus in patients with fundoplicationsSurgical Endoscopy, 2007
- Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation systemSurgical Endoscopy, 2006
- Genomic analysis of Barrett's esophagus after ablative therapy: Persistence of genetic alterations at tumor suppressor lociInternational Journal of Cancer, 2005
- Long-term Outcome of Medical and Surgical Therapies for Gastroesophageal Reflux DiseaseJAMA, 2001
- Recommendations for Reporting Cost-effectiveness AnalysesJAMA, 1996
- Complications and hazards of gastrointestinal endoscopyWorld Journal of Surgery, 1989
- Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagusBritish Journal of Surgery, 1988
- Oesophageal squamous cell carcinoma: I. A critical review of surgeryBritish Journal of Surgery, 1980
- Endoscopic ComplicationsJAMA, 1976